title: Ovarian cancer screening.
abstract: Ovarian cancer is the fourth commonest cause of cancer deaths in women. Multimodal screening with serum CA125 and transvaginal ultrasonography have been shown to improve survival. However, the results so far do not justify routine screening until the impact of screening on mortality has been assessed in larger randomized trials.
authors: Department of Gynaecological Oncology, St Bartholomew's and the Royal London Medical and Dental School, London EC1A 7BE.
authors: Farhad
authors: F
authors: Alexander-Sefre
authors: Usha
authors: U
authors: Menon
authors: Ian J
authors: IJ
authors: Jacobs
mesh_terms: D018394:CA-125 Antigen / Q000097:blood; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D010051:Ovarian Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000000981:diagnostic imaging; D016032:Randomized Controlled Trials as Topic; D012680:Sensitivity and Specificity; D014463:Ultrasonography
chemical_list: D018394:CA-125 Antigen